A detailed history of Hollencrest Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hollencrest Capital Management holds 6,131 shares of MRK stock, worth $601,144. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,131
Previous 5,738 6.85%
Holding current value
$601,144
Previous $710,000 1.97%
% of portfolio
0.03%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$111.15 - $128.97 $43,681 - $50,685
393 Added 6.85%
6,131 $696,000
Q2 2024

Aug 12, 2024

BUY
$123.8 - $132.96 $123 - $132
1 Added 0.02%
5,738 $710,000
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $31,356 - $34,123
313 Added 5.77%
5,737 $625,000
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $102 - $114
1 Added 0.02%
5,424 $558,000
Q1 2023

May 16, 2023

BUY
$102.94 - $114.86 $102 - $114
1 Added 0.02%
5,423 $576,000
Q4 2022

Feb 06, 2023

BUY
$87.44 - $112.11 $474,099 - $607,860
5,422 New
5,422 $601,000
Q2 2022

Jul 21, 2022

BUY
$83.49 - $94.64 $83 - $94
1 Added 0.02%
5,875 $536,000
Q1 2022

Apr 18, 2022

BUY
$73.51 - $82.4 $73 - $82
1 Added 0.02%
5,874 $482,000
Q4 2021

Jan 07, 2022

SELL
$72.28 - $90.54 $7,155 - $8,963
-99 Reduced 1.66%
5,873 $450,000
Q2 2021

Jul 21, 2021

BUY
$70.31 - $77.77 $70 - $77
1 Added 0.02%
5,972 $465,000
Q1 2021

Apr 29, 2021

SELL
$68.86 - $81.11 $48,821 - $57,506
-709 Reduced 10.61%
5,971 $461,000
Q4 2020

Jan 26, 2021

SELL
$71.77 - $79.65 $28,133 - $31,222
-392 Reduced 5.54%
6,680 $547,000
Q3 2020

Oct 13, 2020

BUY
$73.18 - $82.95 $658 - $746
9 Added 0.13%
7,072 $586,000
Q2 2020

Jul 16, 2020

SELL
$70.42 - $80.13 $6,549 - $7,452
-93 Reduced 1.3%
7,063 $546,000
Q1 2020

May 01, 2020

SELL
$63.36 - $87.82 $237,156 - $328,710
-3,743 Reduced 34.34%
7,156 $550,000
Q4 2019

Jan 23, 2020

BUY
$77.58 - $87.54 $37,238 - $42,019
480 Added 4.61%
10,899 $991,000
Q3 2019

Oct 23, 2019

BUY
$76.08 - $82.93 $1,749 - $1,907
23 Added 0.22%
10,419 $877,000
Q2 2019

Jul 18, 2019

BUY
$69.84 - $81.59 $2,584 - $3,018
37 Added 0.36%
10,396 $872,000
Q4 2018

May 09, 2019

SELL
$65.24 - $75.71 $782 - $908
-12 Reduced 0.12%
10,359 $755,000
Q4 2018

Jan 03, 2019

BUY
$65.24 - $75.71 $782 - $908
12 Added 0.12%
10,371 $793,000
Q3 2018

May 09, 2019

SELL
$57.69 - $67.84 $44,075 - $51,829
-764 Reduced 6.87%
10,359 $862,000
Q3 2018

Oct 04, 2018

SELL
$57.69 - $67.84 $19,383 - $22,794
-336 Reduced 2.93%
11,123 $789,000
Q2 2018

Jul 10, 2018

SELL
$50.83 - $59.72 $3,558 - $4,180
-70 Reduced 0.61%
11,459 $0
Q1 2018

Apr 24, 2018

SELL
$50.96 - $59.23 $15,695 - $18,242
-308 Reduced 2.6%
11,529 $628,000
Q4 2017

Jan 19, 2018

SELL
$51.62 - $61.64 $209,061 - $249,642
-4,050 Reduced 25.49%
11,837 $0
Q3 2017

Oct 10, 2017

BUY
$58.67 - $63.13 $932,090 - $1 Million
15,887
15,887 $1.02 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.